Contract Service Directory

Frontage Laboratories, Inc.





Company Headquarters

700 Pennsylvania Drive
Exton, PA 19341
United States

Company Description

Frontage Laboratories, Inc. is a CRO that provides integrated, science-driven, product development services throughout the drug discovery and development process to enable pharmaceutical and biotechnology companies to achieve their development goals. Comprehensive services include drug metabolism and pharmacokinetics, analytical testing and formulation development, preclinical and clinical trial material manufacturing, bioanalysis, preclinical safety and toxicology assessment and early phase clinical studies. Frontage has enabled many biotechnology companies and leading pharmaceutical companies of varying sizes to advance a myriad of molecules through development and file regulatory submissions in the U.S., China and other countries. With an outstanding compliance history, the CMC team operates under strict adherence to ICH and U.S. FDA GMP guidelines. Our broad portfolio of services includes formulation development, and clinical trial material development and production, spanning from preclinical stages through Phase II clinical trials. We have experience with a range of dosage forms, including oral solids/liquids, semi-solids, injectables, and ophthalmics. We have extensive expertise in analytical method development and validation of both small and large molecules, method transfer, as well as commercial product release and stability testing for global markets.

Contract Service Directory

    Related Content

    • Breaking News | CRO News | Facilities | Industry News
      CatSci Expands Capabilities with Lab Expansion

      CatSci Expands Capabilities with Lab Expansion

      Continuing strategic growth.
      CatSci 12.11.19

    • Breaking News | Collaborations & Alliances | Drug Discovery
      IONTAS, Adaptate Enter Antibodies Alliance

      IONTAS, Adaptate Enter Antibodies Alliance

      To generate and optimize antibodies for novel immuno-oncology targets
      12.03.19

    • Bio News | Breaking News | Industry News
      Entera Bio Establishes U.S. HQ in Wellesley, MA

      Entera Bio Establishes U.S. HQ in Wellesley, MA

      Jonathan Lieber will serve as the company's U.S.-based chief financial officer
      11.21.19


    • Frontage Laboratories

      Frontage Laboratories' Hugh Davis

      Frontage's chief business officer highlights the CRO's service offerings.
      Contract Pharma Staff

    • cGMP Manufacture | Drug Development
      Contract Pharma’s 20th Anniversary Series: Catalent

      Contract Pharma’s 20th Anniversary Series: Catalent

      Elliott Berger of Catalent shares his insights on the past 20 years and what we can anticipate for the future of the industry and outsourcing
      Kristin Brooks, Contract Pharma 11.08.19

    • AAPS Exhibitor List

      Company Name Booth # 3D BIOOPTIMA CO., LTD. 1205 AbbVie 2639 AbbVie C1 ABITEC CORPORATION 628 Absorption Systems…
      10.29.19


    • Clinical Trial Materials
      Overcoming the Small Molecule Bioavailability Challenge

      Overcoming the Small Molecule Bioavailability Challenge

      Approximately 90% of preclinical compounds are estimated to face bioavailability challenges.
      David Lyon, Sr. Research Fellow, Lonza Pharma & Biotech 10.15.19

    • cGMP Manufacture
      Deriving Value from Integrated cGMP and Pre-GMP Manufacturing Operations

      Deriving Value from Integrated cGMP and Pre-GMP Manufacturing Operations

      The benefits of leveraging a mix of GMP and pre-GMP facilities.
      Didier Combis, Commercial Director, Seqens CDMO 10.15.19

    • APIs | Cytotoxics and High Potency Manufacturing | Facilities
      Flamma Arrives in the U.S.

      Flamma Arrives in the U.S.

      Italian CDMO sets down roots in the U.S. market with purchase of Teva facility.
      Tim Wright, Editor, Contract Pharma 10.15.19


    • Breaking News | cGMP Manufacture | Chemistry | Drug Development | Industry News
      CMAB Biopharma, BJ Bioscience in Strategic Development and Mfg. Pact

      CMAB Biopharma, BJ Bioscience in Strategic Development and Mfg. Pact

      CMAB will provide a full range of CMC research and manufacturing services to support IND applications for China and the U.S.
      10.11.19

    • Breaking News | CRO News | Industry News
      VIDEO: Frontage Laboratories

      VIDEO: Frontage Laboratories' Hugh Davis

      Frontage's chief business officer highlights the CRO's service offerings.
      10.09.19

    • Bioanalytical Services | Biologics, Proteins, Vaccines | Industry News | Laboratory Testing
      Frontage Expands Bioanalytical Capacity and Capabilities

      Frontage Expands Bioanalytical Capacity and Capabilities

      To add 10,000 square feet of lab space to support biologic drug development, biomarkers and cell and gene therapy
      10.03.19


    • Biologics, Proteins, Vaccines | cGMP Manufacture | Drug Development
      Continued and Consistent Investment in Manufacturing Facilities

      Continued and Consistent Investment in Manufacturing Facilities

      As companies move their cell and gene therapies through the development process, supporting larger Phase III trials and commercial launches will be a challenge
      Ryan Carpentier, Executive Director of Business Development, Cryoport 09.23.19

    • Contracting And Outsourcing Exhibitor List

      2019 Exhibitors Company Table 3C PACKAGING 138 Adare Pharmaceuticals 97 Adents 123 Admix Pharma Labs 135 Advanced Analytical…
      09.17.19

    • Breaking News | Facilities | Industry News
      Frontage Clinical Expands NJ Facilities

      Frontage Clinical Expands NJ Facilities

      Can now accommodate tobacco and nicotine-related studies
      08.14.19

    • Promotions & Moves
      Mereo BioPharma Appoints Head of Pharma Development

      Mereo BioPharma Appoints Head of Pharma Development

      Richard Francis brings more than 35 years of experience in biopharmaceutical process development and manufacturing operations
      07.16.19